Additionally, CK1α was found to be essential for acute myeloid leukemia (AML) viability, and treatment with the CK1 inhibitor D4476 resulted in selective killing of the AML cells [91]. This evidence concerns the gene CSNK1A1 and acute myeloid leukemia.